Federated Hermes’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.3M Buy
740,297
+76,543
+12% +$1.82M 0.03% 493
2025
Q4
$15.5M Buy
663,754
+274,465
+71% +$6.11M 0.03% 512
2025
Q3
$7.67M Buy
389,289
+134,509
+53% +$2.77M 0.01% 630
2025
Q2
$5.53M Buy
254,780
+180,296
+242% +$4.26M 0.01% 707
2025
Q1
$1.81M Sell
74,484
-99,906
-57% -$2.25M ﹤0.01% 957
2024
Q4
$3.64M Buy
174,390
+120,249
+222% +$2.58M 0.01% 792
2024
Q3
$1.08M Buy
54,141
+163
+0.3% +$3.02K ﹤0.01% 1094
2024
Q2
$836K Sell
53,978
-3
-0% -$47 ﹤0.01% 1168
2024
Q1
$860K Sell
53,981
-75,183
-58% -$1.13M ﹤0.01% 1181
2023
Q4
$2.17M Sell
129,164
-41,844
-24% -$572K 0.01% 928
2023
Q3
$2M Buy
171,008
+76,264
+80% +$1.02M 0.01% 921
2023
Q2
$1.27M Buy
94,744
+53,478
+130% +$770K ﹤0.01% 1081
2023
Q1
$684K Sell
41,266
-24
-0.1% -$396 ﹤0.01% 1303
2022
Q4
$768K Buy
41,290
+41,080
+19,562% +$632K ﹤0.01% 1223
2022
Q3
$4K Sell
210
-843
-80% -$9.99K ﹤0.01% 1905
2022
Q2
$8K Sell
1,053
-655,319
-100% -$4.81M ﹤0.01% 1847
2022
Q1
$5.44M Sell
656,372
-1,082
-0.2% -$7.65K 0.01% 759
2021
Q4
$4.45M Buy
657,454
+215
+0% +$1.41K 0.01% 845
2021
Q3
$3.48M Buy
657,239
+30,242
+5% +$165K 0.01% 907
2021
Q2
$3.6M Buy
626,997
+119
+0% +$614 0.01% 927
2021
Q1
$2.89M Sell
626,878
-4,973
-0.8% -$19.8K 0.01% 1000
2020
Q4
$2.11M Sell
631,851
-981
-0.2% -$3.3K ﹤0.01% 1044
2020
Q3
$1.88M Buy
632,832
+73,385
+13% +$287K ﹤0.01% 1018
2020
Q2
$2.58M Buy
559,447
+298,251
+114% +$1.34M 0.01% 901
2020
Q1
$1M Buy
261,196
+251,854
+2,696% +$1.03M ﹤0.01% 1142
2019
Q4
$35K Sell
9,342
-113,375
-92% -$530K ﹤0.01% 1776
2019
Q3
$652K Buy
122,717
+120,775
+6,219% +$643K ﹤0.01% 1395
2019
Q2
$7K Buy
+1,942
New +$8.39K ﹤0.01% 1936
2018
Q1
Sell
-597
Closed -$2K 2166
2017
Q4
$2K Buy
+597
New +$1.97K ﹤0.01% 2067
2016
Q2
Sell
-5,091,120
Closed -$5.96M 2107
2016
Q1
$5.96M Buy
5,091,120
+508,800
+11% +$789K 0.02% 510
2015
Q4
$11.2M Hold
4,582,320
0.04% 419
2015
Q3
$13.7M Buy
4,582,320
+18,520
+0.4% +$79.9K 0.04% 370
2015
Q2
$18.8M Buy
4,563,800
+2,578,800
+130% +$10.3M 0.06% 324
2015
Q1
$8.6M Buy
1,985,000
+550,000
+38% +$1.98M 0.03% 489
2014
Q4
$4.26M Sell
1,435,000
-1,613,500
-53% -$4.43M 0.01% 668
2014
Q3
$10.1M Sell
3,048,500
-136,500
-4% -$357K 0.03% 440
2014
Q2
$8.06M Sell
3,185,000
-82,000
-3% -$175K 0.03% 513
2014
Q1
$7.38M Buy
3,267,000
+12,040
+0.4% +$25.2K 0.02% 546
2013
Q4
$6.35M Sell
3,254,960
-30,040
-0.9% -$60.7K 0.02% 568
2013
Q3
$10M Sell
3,285,000
-749,207
-19% -$1.26M 0.04% 380
2013
Q2
$3.59M Buy
+4,034,207
New +$3.23M 0.01% 678

Other funds holding CPRX